those reported previously (Xi et al., 2006) . After 5-7 d of recovery from surgery, each rat was placed into a standard operant chamber and allowed to lever-press for i.v. cocaine (1 mg/kg/infusion) self-administration under a fixed-ratio 1 (FR1) reinforcement schedule. After 5 days of cocaine self-administration, the cocaine dose was changed from 1 mg/kg per infusion to 0.5 mg/kg per infusion under FR2 reinforcement, with a maximal number of 50 infusions for an additional 2-3 weeks until stable day-to-day self-administration was established. Stable selfadministration was defined as (i) at least 20 infusions per 3-h session, (ii) less than 20% variability in daily cocaine infusions across two consecutive sessions, and (iii) an active/inactive lever press ratio exceeding 2:1 (2, 3). In the nicotine self-administration experiment, the nicotine dose (60 µg/kg/infusion) was kept the same during the initial 5 sessions under FR1 and the following sessions under FR2 reinforcement. The self-administration patterns, total leverpressing numbers, and rates of cocaine infusion and lever responses were compared in WT and mGluR2-KO rats. The effects of systemic administration of LY-379268 on cocaine selfadministration under FR2 reinforcement were evaluated after the stable self-administration was achieved.
Multiple-dose cocaine self-administration
We also observed and compared cocaine self-administration maintained by a full range of cocaine doses (0.031, 0.063, 0.125, 0.25, 0.5 and 1.0 mg/kg per infusion) in a single session between two strains of rats with the procedures we used previously (Keck et al., 2013) . The session consisted of six sequential 20-min components, each preceded by a 20-min time-out period for changing cocaine dose. The infusion volumes and durations in each component were identical, except that cocaine concentrations for corresponding unit cocaine doses differed.
There was a 30-min extinction period (0 mg/kg cocaine) before daily cocaine selfadministration training. Training continued until stable cocaine-maintained responding was achieved. Self-administration patterns, total numbers of cocaine infusions, and rates of drug intake were compared in WT and mGluR2-KO rats.
Progressive-ratio cocaine self-administration
To further determine whether mGluR2 deletion alters the motivation to work for cocaine reward, we switched an additional group of animals to progressive ratio (PR) reinforcement after initial FR1 cocaine self-administration. The procedures for PR cocaine self-administration have been described previously (Xi et al., 2008) . We then compared the total numbers of cocaine infusions and breakpoint levels in WT and mGluR2-KO rats. And then, the effects of systemic administration of LY-379268 on cocaine self-administration under PR reinforcement were evaluated after the stable self-administration was achieved.
.
Extinction and cocaine-induced reinstatement
After stable self-administration was achieved, an additional group of rats underwent extinction, during which cocaine and the cocaine-associated cue light and tone were unavailable, and lever pressing was recorded but had no consequence. Daily extinction sessions continued for 2-3 weeks. Each extinction session lasted for 3 h. Then each animal received 3 mg/kg or 10 mg/kg of cocaine i.p. to evoke reinstatement of drug-seeking behavior. Extinction and cocaine-induced reinstatement were compared in WT and mGluR2-KO rats. The effects of systemic administration of LY-379268 on cocaine-induced reinstatement were evaluated in additional groups of rats based on between-subject design.
Cue-induced cocaine-seeking behavior
Additional groups of WT and mGluR2-KO rats were used in this experiment. After stable cocaine self-administration was achieved as described above, the animals underwent withdrawal for 1-2 weeks in the animal facility. On the test days, rats were placed into the same selfadministration chambers in which they were trained, and cocaine-associated cue-induced drugseeking behavior (i.e., extinction responding) was assessed under extinction conditions during which cocaine and cocaine-associated discrete cue light and tone were unavailable and lever pressing resulted in no consequences. Each extinction session lasted 3 h. Each animal was tested three times on day 2, day 7 and day 14 after cocaine withdrawal.
Oral sucrose self-administration
The procedures for oral sucrose self-administration were identical to the comparable procedures for cocaine, except that no surgery was performed on the animals in the sucrose experiment, each session lasted 1 hr, and active lever presses led to the delivery of 0.02 mL of 5% sucrose solution into a liquid food tray on the operant chamber wall with maximal 100 sucrose deliveries per session.
Locomotor Activity
Before cocaine administration, each animal was placed into a locomotor detection chamber (Accuscan Instruments) for 3 d (3 h per day) for environmental habituation. On each test day, rats were placed in the chamber for 1 h of habituation, then removed and given either saline or cocaine (15 mg/kg i.p.). The rats were then placed back into the locomotor chambers for 2 h to assess the effects of cocaine on locomotion. The order of testing for the vehicle or cocaine was counter-balanced. Data were collected in 10-min intervals using the VersaMax data analysis system (Accuscan Instruments). The distance traveled was used to compare basal and cocaineenhanced locomotion in WT and mGluR2-KO rats.
Rotarod test
To determine whether mGluR2 deletion alters locomotor performance or locomotor coordination ability, we observed rotarod performance of two groups of rats on a fast-running rotarod device.
Performance on an accelerating rotarod was assessed using a four-station rat rotarod (AccuScan Instruments Inc., Columbus, Ohio, USA). The speed of rotation of the rotarod was increased from 2.5 to 20 rpm over 2 min and the time (Sec) the animal remained on the rod was determined as the mean of three trials. After 2-3 days of habituation and training on the rotarod device, animals were placed on the rotarod device to observe their locomotor performance for 5 consecutive days (30 min per day per rat).
Hot plate test
Pain reflexes in response to a thermal stimulus were measured in rats using a hotplate test.
Briefly, rats were placed on the hotplate (55 ± 0.4°C). The response was defined by the animal forepaw licking; 30 s was the cutoff time to avoid tissue damage. Baseline was established 1 d before the drug testing day by performing several trials 2 min apart until steady latency is obtained. The basal response time (seconds) was compared between the two strains of rats.
Elevated plus maze test
The elevated plus maze is made of medium-density fiberboard with a matte black acrylic surface, Each animal was tested for 5 times with 1 hr inter-trial interval on the test day.
Immunoblot Assays
Rats were perfused transcardially with cold 0.9% saline under deep anesthesia. Cerebral cortex, hippocampus, striatum and cerebellum were dissected. Tissues were homogenized with NuPAGE lysis buffer (Cell Signaling Technology) and the protein concentration for each sample was quantified with a Bio-Rad protein assay. A total of 30 µg of protein was used for the immunoblot assay. Membranes were then incubated with rabbit polyclonal mGluR2 antibody (with an intracellular epitope of rat mGluR2, amino acids 829-845) (Millipore, 07-261, 1:500), rabbit polyclonal mGluR3 antibody (with an extracellular epitope of rat mGluR3) (Alomone, AGC-012, 1:500), or mouse monoclonal β-actin antibody (Sigma-Aldrich, Cat.# A3853, 1:2000), and then incubated with the second antibodies [IRDye 800CW donkey anti-rabbit IgG (H+L) (LI-COR Biosciences) for mGluR2 or mGluR3, or IRDye 680CW donkey anti-mouse IgG (H+L) for β-actin (LI-COR Biosciences)]. Membranes were then scanned using a LI-COR Odyssey Image System. The mGluR2 immunoblot band was predicted at 97 kD, mGluR3 was predicted at 100 kD, and β-actin was predicted at 40-45 kDa.
Immunohistochemistry Assays
After 2 weeks of withdrawal from the last cocaine self-administration, rats were deeply anesthetized and perfused transcardially with cold 0.9% (wt/vol) saline, followed by 4% (vol/vol) paraformaldehyde in 0.1 M phosphate buffer. Brain tissues were then transferred to 20% (wt/vol) sucrose in phosphate buffer at 4 °C overnight. Coronal sections were cut at 12 µm with a cryostat (CM3050S; Leica Microsystems). Tissue sections containing the striatum were blocked and floated in 4% (wt/vol) BSA and 0.3% (vol/vol) Triton X-100 phosphate buffer for 2 h at room temperature. Immunohistochemistry was then performed using mouse monoclonal NR2A antibody (EMD Millipore, MAB5216, 1:250) or mouse monoclonal NR2B antibody (EMD Millipore, MAB5220, 1:250), and goat polyclonal anti-DARPP-32 (N-19) (Santa Cruz Biotechnology, Inc, sc-8483, 1:250). After washing, sections were further incubated with a mixture of secondary antibodies: Alexa Fluor 488 donkey anti-mouse IgG (H+L) (Life Technology, A21202, 1:500) for NR2A or NR2B and Alexa Fluor 568 donkey anti-goat IgG (H+L) (Life Technology, A11057, 1:500) for DARPP-32 in 4% BSA and 0.3% Triton X-100 phosphate buffer for 2 h at room temperature. Sections were then washed, mounted, and cover slipped. Fluorescent images were obtained with a fluorescence microscope (Nikon Eclipse 80i) equipped with a digital camera. All images were taken under identical optical conditions. Densitometric analysis was used to quantify NR2B immunostaining density on individual brain slices containing striatum using ImageJ software.
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